This guidance document includes an updated summary of diagnostic PCR and serology together with detailed information on isolation, culture, identification and epidemiological typing of B. pertussis to help users choose the best methods within the local technical and financial provisions.
Version 6.1 is the final protocol for the third EU-wide point prevalence survey in acute care hospitals (PPS 2022–2023). It contains important changes compared to protocol version 5.3 (PPS 2016–2017), including on healthcare-associated COVID-19.
Anthrax continues to be a rare disease in humans in Europe, with only a few cases reported every year. For 2017, two European Union/European Economic Area (EU/EEA) countries reported six confirmed anthrax cases (Romania reported five cases and Bulgaria one). The remaining 28 reporting countries did not notify any confirmed cases.
Anthrax continues to be an uncommon disease in humans in Europe, with only a few cases reported every year. For 2018, three confirmed anthrax cases were reported, one each in Netherlands, Romania and Spain. Twenty-seven EU/EEA countries notified zero confirmed cases.